Catalyst Biosciences Inc Shares Close in on 52-Week Low - Market Mover
The shares closed 0.5% above its 52-week low of $0.83, with trading volume lower than its 30 day average
Jan 09, 2022 by Kwhen Finance Editors
Catalyst Biosciences Inc (CBIO) shares closed today at 0.5% above its 52 week low of $0.83, giving the company a market cap of $26M. The stock is currently down 8.5% year-to-date, down 86.5% over the past 12 months, and down 91.9% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%.
Trading Activity
- Trading volume this week was 34.0% lower than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 0.9.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
---|---|---|---|---|---|
Catalyst Biosciences Inc | -2.3 | -8.5 | -86.5 | -88.6 | 3.4 |
Dow Jones Industrial Average | -0.0 | -0.3 | 18.7 | -2.0 | 23.2 |
S&P 500 Index | -0.4 | -1.9 | 24.6 | -2.5 | 28.8 |
Health Care | -0.7 | -5.2 | 13.5 | -5.5 | 21.4 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by -559.5%
- The company's stock price performance over the past 12 months lags the peer average by 507.3%
Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
---|---|---|---|---|---|---|
Catalyst Biosciences Inc | CBIO | -0.3 | -8.5 | -86.5 | -88.6 | 3.4 |
Peer Avg | N/A | 4.6 | 1.9 | -14.2 | -21.7 | 12.3 |
National Research Corp | NRC | 28.8 | -1.8 | -7.9 | -25.5 | 5.4 |
Nymox Pharmaceutical Corp | NYMX | -10.4 | 9.2 | -49.1 | -61.4 | 43.6 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: